Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2021-08-16 18:04:19 UTC |
---|
NP-MRD ID | NP0001217 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Quinaldic acid |
---|
Description | Quinaldic acid, also known as quinaldate, 2-carboxyquinoline, or quinoline-2-carboxylic acid, belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. The quinoline ring system is a double-ring structure composed of a benzene and a pyridine ring fused at two adjacent carbon atoms. Quinaldic acid is a quinoline having a carboxy group at the 2-position. It is a solid that is moderately soluble in water with a melting point of 156°C. Quinaldic acid is a metabolite of tryptophan degradation that is formed via the kynurenine pathway; it is formed through the dehydroxylation of the intermediate kynurenic acid (PMID: 13385219 ). It is excreted in urine, and its urine concentration is decreased in individuals suffering from chronic alcoholism (PMID: 25754126 ). Quinaldic acid has been shown to inhibit proinsulin synthesis in pancreatic islet cells (PMID: 373355 ). Quinaldic acid has been shown to have anti-proliferative or anti-tumour effects and has been found to alter the expression of the p53 tumour suppressor gene as well as the phosphorylation of the p53 protein in in vitro studies (PMID: 30780127 ). |
---|
Structure | OC(=O)C1=NC2=C(C=CC=C2)C=C1 InChI=1S/C10H7NO2/c12-10(13)9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,(H,12,13) |
---|
Synonyms | Value | Source |
---|
2-Carboxyquinoline | ChEBI | 2-Chinolincarbonsaeure | ChEBI | 2-Quinolinecarboxylate | ChEBI | 2-Quinolinecarboxylic acid | ChEBI | Chinaldinsaeure | ChEBI | Quinaldate | ChEBI | Quinaldinic acid | ChEBI | Quinoline-2-carboxylic acid | ChEBI | Quinaldinate | Generator | Quinoline-2-carboxylate | Generator | 2-Quinolinylcarboxylate | HMDB | 2-Quinolinylcarboxylic acid | HMDB | Quinolin-2-carboxylate | HMDB | Quinolin-2-carboxylic acid | HMDB | Quinaldic acid | KEGG |
|
---|
Chemical Formula | C10H7NO2 |
---|
Average Mass | 173.1681 Da |
---|
Monoisotopic Mass | 173.04768 Da |
---|
IUPAC Name | quinoline-2-carboxylic acid |
---|
Traditional Name | quinaldic acid |
---|
CAS Registry Number | 93-10-7 |
---|
SMILES | OC(=O)C1=NC2=C(C=CC=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C10H7NO2/c12-10(13)9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,(H,12,13) |
---|
InChI Key | LOAUVZALPPNFOQ-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as quinoline carboxylic acids. These are quinolines in which the quinoline ring system is substituted by a carboxyl group at one or more positions. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Quinolines and derivatives |
---|
Sub Class | Quinoline carboxylic acids |
---|
Direct Parent | Quinoline carboxylic acids |
---|
Alternative Parents | |
---|
Substituents | - Quinoline-2-carboxylic acid
- Pyridine carboxylic acid
- Pyridine carboxylic acid or derivatives
- Benzenoid
- Pyridine
- Heteroaromatic compound
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Azacycle
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 156 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 14 mg/mL | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Epand RM: The role of dietary ergothioneine in the development of diabetes mellitus. Med Hypotheses. 1982 Aug;9(2):207-13. [PubMed:7144630 ]
- Okamoto H, Miyamoto S, Mabuchi H, Takeda R: Inhibition effect of quinaldic acid on glucose-induced insulin release from isolated Langerhans islets of the rat. Biochem Biophys Res Commun. 1974 Jul 24;59(2):623-9. [PubMed:4368820 ]
- Ektova LV, Iartseva IV, Khorosheva EV, Ivanova TP, Iavorskaia NP, Mel'nik SIa: [Synthesis and biological properties of pyrimidine 2'-deoxynucleosides modified by a residue of quinaldic acid]. Bioorg Khim. 1995 Aug;21(8):625-31. [PubMed:8540903 ]
- Liu SY, Zhang RL, Kang H, Fan ZJ, Du Z: Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol. 2013 Jun 14;19(22):3423-32. doi: 10.3748/wjg.v19.i22.3423. [PubMed:23801834 ]
- Okamoto H: Effect of quinaldic acid and its relatives on insulin-release from isolated Langerhans islets. Acta Vitaminol Enzymol. 1975;29(1-6):227-31. [PubMed:801703 ]
- KAIHARA M, PRICE JM, TAKAHASHI H: The conversion of kynurenic acid to quinaldic acid by humans and rats. J Biol Chem. 1956 Dec;223(2):705-8. [PubMed:13385219 ]
- Mittal A, Dabur R: Detection of new human metabolic urinary markers in chronic alcoholism and their reversal by aqueous extract of Tinospora cordifolia stem. Alcohol Alcohol. 2015 May;50(3):271-81. doi: 10.1093/alcalc/agv012. Epub 2015 Mar 8. [PubMed:25754126 ]
- Noto Y, Okamoto H: Inhibition by kynurenine metabolites of proinsulin synthesis in isolated pancreatic islets. Acta Diabetol Lat. 1978 Sep-Dec;15(5-6):273-82. doi: 10.1007/BF02590750. [PubMed:373355 ]
- Langner E, Jeleniewicz W, Turski WA, Plech T: Quinaldic acid induces changes in the expression of p53 tumor suppressor both on protein and gene level in colon cancer LS180 cells. Pharmacol Rep. 2019 Apr;71(2):189-193. doi: 10.1016/j.pharep.2018.10.016. Epub 2018 Oct 30. [PubMed:30780127 ]
|
---|